Kanepiürt: erinevus redaktsioonide vahel

Eemaldatud sisu Lisatud sisu
P →‎Viited: Viitamismallide vead: kuupäev
P Kuupäevad eestipäraseks: aaaa-kk-pp -> pp.kk.aaaa
74. rida:
<ref name="dWWvy">{{Cite journal|author=El-Remessy AB, Al-Shabrawey M, Khalifa Y, Tsai NT, Caldwell RB, Liou GI |title=Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes |journal=The American Journal of Pathology |volume=168 |issue=1 |pages=235–44 |year=2006 |pmid=16400026 |pmc=1592672 |doi=10.2353/ajpath.2006.050500 |format=Free full text}}</ref>
<ref name="cFY3d">{{Cite journal|author=Fox SH, Kellett M, Moore AP, Crossman AR, Brotchie JM |title=Randomised, double-blind, placebo-controlled trial to assess the potential of cannabinoid receptor stimulation in the treatment of dystonia |journal=Movement Disorders |volume=17 |issue=1 |pages=145–9 |year=2002 |pmid=11835452 |doi=10.1002/mds.1280}}</ref>
<ref name="3TSDM">{{cite web|url=http://www.telegraph.co.uk/science/science-news/8440303/Cannabis-could-be-used-to-treat-epilepsy.html |title=Cannabis could be used to treat epilepsy |publisher=Telegraph |date=2011-04-10.04.2011 |accessdate=2011-04-20.04.2011}}</ref>
<ref name="KnO3S">{{Cite journal|author=Marsicano G, Goodenough S, Monory K, ''et al.'' |title=CB1 cannabinoid receptors and on-demand defense against excitotoxicity |journal=Science |volume=302 |issue=5642 |pages=84–8 |year=2003 |pmid=14526074 |doi=10.1126/science.1088208 |last12=Casanova |first12=E |last13=Schütz |first13=G |last14=Zieglgänsberger |first14=W |last15=Di Marzo |first15=V |last16=Behl |first16=C |last17=Lutz |first17=B}}</ref>
<ref name="NlsWP">{{Cite journal|author=Bacci A, Huguenard JR, Prince DA |title=Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids |journal=Nature |volume=431 |issue=7006 |pages=312–6 |year=2004 |pmid=15372034 |doi=10.1038/nature02913 |laysummary=http://www.sciencedaily.com/releases/2004/09/040916102315.htm |laysource=[[Science Daily]] |laydate=16. september 2004}}</ref>
81. rida:
<ref name="wAp7t">{{Cite journal|author=Ramer R, Hinz B |title=Inhibition of cancer cell invasion by cannabinoids via increased expression of tissue inhibitor of matrix metalloproteinases-1 |journal=Journal of the National Cancer Institute |volume=100 |issue=1 |pages=59–69 |year=2008 |pmid=18159069 |doi=10.1093/jnci/djm268 |format=Free full text}}</ref>
<ref name="OS9NM">{{Cite journal|author=Sylvestre DL, Clements BJ, Malibu Y |title=Cannabis use improves retention and virological outcomes in patients treated for hepatitis C |journal=European Journal of Gastroenterology & Hepatology |volume=18 |issue=10 |pages=1057–63 |year=2006 |pmid=16957511 |doi=10.1097/01.meg.0000216934.22114.51}}</ref>
<ref name="LdH0k">{{Cite journal|author=Powles T, te Poele R, Shamash J, ''et al.'' |title=Cannabis-induced cytotoxicity in leukemic cell lines: the role of the cannabinoid receptors and the MAPK pathway |journal=Blood |volume=105 |issue=3 |pages=1214–21 |year=2005 |pmid=15454482 |doi=10.1182/blood-2004-11.03-1182.200482 |format=Free full text}}</ref>
<ref name="vjyDR">{{Cite journal|author=Casanova ML, Blázquez C, Martínez-Palacio J, ''et al.'' |title=Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors |journal=The Journal of Clinical Investigation |volume=111 |issue=1 |pages=43–50 |year=2003 |pmid=12511587 |pmc=151833 |doi=10.1172/JCI16116 |format=Free full text}}</ref>
<ref name="JtltT">{{Cite journal|author=Kreitzer AC, Malenka RC |title=Endocannabinoid-mediated rescue of striatal LTD and motor deficits in Parkinson's disease models |journal=Nature |volume=445 |issue=7128 |pages=643–7 |year=2005 |pmid=17287809 |doi=10.1038/nature05506 |laysummary=http://med.stanford.edu/news_releases/2007/february/malenka.html |laysource=[[Stanford University School of Medicine]] |laydate=7. veebruar 2007}}</ref>